Cargando…
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
Cathepsin G (CG) is a myeloid azurophil granule protease that is highly expressed by acute myeloid leukemia (AML) blasts and leukemia stem cells. We previously identified CG1 (FLLPTGAEA), a human leukocyte antigen-A2-restricted nonameric peptide derived from CG, as an immunogenic target in AML. In t...
Autores principales: | Khan, Maliha, Carmona, Selena, Sukhumalchandra, Pariya, Roszik, Jason, Philips, Anne, Perakis, Alexander A., Kerros, Celine, Zhang, Mao, Qiao, Na, John, Lisa S. St., Zope, Madhushree, Goldberg, Jonathan, Qazilbash, Mariam, Jakher, Haroon, Clise-Dwyer, Karen, Qiu, Yihua, Mittendorf, Elizabeth A., Molldrem, Jeffrey J., Kornblau, Steven M., Alatrash, Gheath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790053/ https://www.ncbi.nlm.nih.gov/pubmed/29422892 http://dx.doi.org/10.3389/fimmu.2017.01975 |
Ejemplares similares
-
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
por: Alatrash, Gheath, et al.
Publicado: (2016) -
Targeting PR1 in myeloid leukemia
por: Alatrash, Gheath, et al.
Publicado: (2017) -
Activity of 8F4, a T cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo
por: Sergeeva, Anna, et al.
Publicado: (2016) -
A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2
por: Herrmann, Amanda C., et al.
Publicado: (2019) -
Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013)